Document Type : Final File


Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran, Islamic Republic of Iran


Activin A is a member of the transforming growth factor β super family. Because of its extensive clinical usages, its recombinant production is beneficial. In this study, activin A was expressed in E. coli using the pET 21a expression vector. The optimization of the activin A production in E. coli was done by using the response surface methodology (RSM). At this stage, the effect of IPTG and lactose concentration as inducers on protein production was investigated. The effect of different post-induction time and temperature on protein production was then studied in two strains of E. coli (BL21(DE3) and BL21(DE3) plysS). For enhanced expression, the optimum IPTG and lactose concentrations were 1.5 mM and 0% W/V respectively. In the DE3 strain, the optimum post-induction time and temperature were 10 hours and 30°C respectively while in DE3 (plysS) these were 4 hours and 35°C respectively


Main Subjects

  1. Walton K.L., Makanji Y. and Harrison C.A. New insights into the mechanisms of activin action and inhibition. Mol. Cell. Endocrinol359(1): 2-12 (2012).
  2. Hinck A.P. Structural studies of the TGF-βs and their receptors – insights into evolution of the TGF-β superfamily. FEBS Lett. 586(14): 1860-70 (2012).
  3. Chen Y.G., Wang Q., Lin S.L., Chang C.D., Chung J. and Ying S.Y. Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis. Exp.Biol.Med231(5): 534-544 (2006).
  4.  Fang L., Wang Y.N., Cui X.L., Fang S.Y, Ge J.Y., Sun Y. and Liu Z.H. The role and mechanism of action of activin A in neurite outgrowth of chicken embryonic dorsal root ganglia. J.cell.sci. 125: 1500-1507 (2012).
  5. Sulyok S., Wankell M., Alzheimer C. and Werner S. Activin: an important regulator of wound repair, fibrosis, and neuroprotectionMol.Cell.Endocrinol. 225(1): 127-132 (2004).
  6. Cronin C.N., Thompson D.A. and Martin F. Expression of bovine activin-A and inhibin-A in recombinant baculovirus-infected Spodoptera frugiperdaSf21 insect cells. Int.J.Biochem.Cell Biol30(10): 1129-1145 (1998).
  7. Papakonstantinou T., Harris S.J., Fredericks D., Harrison C., Wallace E.M. and Hearn M.T. Synthesis, purification and bioactivity of recombinant human activin A expressed in the yeast Pichia pastoris. Protein.Expr.Purif64(2): 131-138 (2009).
  8. Pangas S.A. and Woodruff T.K. Production and purification of recombinant human inhibin and activin. J.Endocrinol. 172(1): 199-210 (2002).
  9. Rosano G.L. and Ceccarelli E.A. Recombinant protein expression in Escherichia coli: advances and challengesFront.Microbiol7: (2014).

10. Gopal G.J. and Kumar A. strategies for the production of recombinant protein in escherichia coli. Protein J32(6): 419-25 (2013).

11. Tegel H., Ottosson J. and Hober S. Enhancing the protein production levels in Escherichia coli with a strong promoter. The FEBS J278(5): 729-739 (2011).

12. Saez N.J. and Vincentelli R. High-throughput expression screening and purification of recombinant proteins in E. coli. Methods.Mol.Biol.  1091: 33-53 (2014).

13. Draper N.R. Response surface methodology: Process and product optimization using designed experiments: RH Myers and DC Montgomery. Wiley, New York, 714 pp. (1997).

14. Dubey S., Singh A. and Banerjee U.C. Response surface methodology of nitrilase production by recombinant Escherichia coli. Braz. J. Microbiol. 42(3): 1085-92 (2011).



 Donovan R.S., Robinson C.W. and Glick B.R. Review: optimizing inducer and culture conditions for expression of foreign proteins under the control of the lac promoter. J.Ind. Microbiol.Biotechnol. 16(3): 145-154 (1996).

16. Gholami Tilko P., Hajihassan Z. and Moghimi H. Optimization of recombinant β-NGF expression in Escherichia coli using response surface methodology. Prep.Biochem. Biotechnol. 47(4): 406-413 (2017).

17. Savari M., Esfahani S. H. Z., Edalati M. and Biria D. Optimizing conditions for production of high levels of soluble recombinant human growth hormone using Taguchi method. Protein.Expr.Purif114: 128-135 (2015).

18. Larentis A.L., Argondizzo A.P.C., dos Santos Esteves G., Jessouron E., Galler R. and Medeiros, M.A. Cloning and optimization of induction conditions for mature PsaA (pneumococcal surface adhesin A) expression in Escherichia coli and recombinant protein stability during long-term storage. Protein.Expr.Purif78(1): 38-47 (2011).

19. Sambrook J. and Russell D.W.S. The condensed protocols from molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press. (2006).

20. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal.Biochem72(1-2): 248-254 (1976).

21. Schneider C.A., Rasband W.S. and Eliceiri K.W. NIH Image to ImageJ: 25 years of image analysis. Nature methods9(7): 671 (2012).

22. Papaneophytou C.P., Rinotas V., Douni E. and Kontopidis G. A statistical approach for optimization of RANKL overexpression in Escherichia coli: Purification and characterization of the protein. Protein.Expr.Purif.  90(1): 9-19 (2013).